Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Medicover in connection with a directed share issue
Mandate

Vinge advises Medicover in connection with a directed share issue 

June 11, 2020 Capital Markets and Public M&A

The board of directors of Medicover has, on the basis of an authorisation granted from the annual general meeting, resolved on a directed new issue of shares, whereby Medicover will raise proceeds of SEK 1.5 billion, before issue costs.

The share issue is directed to a large number of Nordic and international institutional investors, on the basis of an accelerated bookbuilding process carried out by SEB. 
 
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2019, Medicover had revenue around €844 million and 28,800 employees.
 
Vinge’s team has consisted of Dain Hård Nevonen, Sofie Bjärtun and Eléonore Friberg. 

Related

Vinge has advised Viva Wine Group AB in connection with the acquisition of the Norwegian beverage company Alpha Brands

 Vinge has advised Viva Wine Group AB in connection with the acquisition of 60 percent of the shares in the Norwegian beverage company Alpha Brands, for an initial cash purchase price of MNOK 33, with a possible earn-out based on the company's performance development.
February 09, 2026

Vinge advises HAKI Safety AB (publ) in connection with the acquisition of Newbow Aerospace Limited

 Newbow Aerospace is a UK-based market-leading manufacturer and supplier of ground support equipment (GSE) used for the safe and efficient maintenance of aircraft.
February 09, 2026

Vinge advises Borgo in connection with its inaugural issuance of primary capital instruments (AT1)

 Vinge has advised Borgo AB (publ) in connection with its successful issuance of primary capital instruments (so called “AT1 bonds”) in the amount of SEK 350 million with a floating rate coupon of 3-month STIBOR + 390 basis points.
January 29, 2026